If all three warrant tranches are exercised, Unicycive Therapeutics (UNCY) is expected to add a total of 15,818,817 shares. These tranches, often referred to in financing contexts, are designed to trigger 21 days after the public disclosure of four consecutive quarters of commercial sales, potentially bringing in $103.2 million in capital.
So we got about 25 million outstanding now and go to 40 million….nothing to worry about ….imo ….could be a heck of a lot worse ….relax
Market Data 
Markets 
AI
